<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Efentakis, P</style></author><author><style face="normal" font="default" size="100%">Iliodromitis, E.K.</style></author><author><style face="normal" font="default" size="100%">Varela, A.</style></author><author><style face="normal" font="default" size="100%">Chavdoula, E</style></author><author><style face="normal" font="default" size="100%">Sigala, F</style></author><author><style face="normal" font="default" size="100%">Kostomitsopoulos, N.</style></author><author><style face="normal" font="default" size="100%">Farmakis, D.</style></author><author><style face="normal" font="default" size="100%">Tasouli, A</style></author><author><style face="normal" font="default" size="100%">Papapetropoulos, A.</style></author><author><style face="normal" font="default" size="100%">Klinakis, A</style></author><author><style face="normal" font="default" size="100%">others</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">P4229Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action</style></title><secondary-title><style face="normal" font="default" size="100%">European Heart Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2017</style></year></dates><number><style face="normal" font="default" size="100%">suppl\_1</style></number><publisher><style face="normal" font="default" size="100%">Oxford University Press</style></publisher><volume><style face="normal" font="default" size="100%">38</style></volume><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>